Herpes Zoster Treatment Market Expected to Reach $303.42 Million by 2030

According to a new report published by Allied Market Research, titled, "Herpes Zoster Treatment Market by, Treatment Type, Route of Administration, Distribution Channel and Region: Global Opportunity Analysis and Industry Forecast, 2021–2030," the global herpes zoster treatment market size was valued at $217.09 million in 2020, and is projected to reach $303.42 million by 2030, registering a CAGR of 3.4% from 2021 to 2030.

Herpes zoster, also known as shingles, is a viral infection that causes painful rashes on skin, which occurs in patients having immunosuppressive diseases or cell-mediated immunity that declines with age. Herpes zoster is caused by the varicella zoster virus, the same virus that causes chicken pox as well. After a person has chicken pox, the virus lies dormant in certain nerves for years and its reactivation causes herpes zoster infection.

Furthermore, people with herpes zoster can infect someone who has never had chicken pox, but the person will only get chicken pox and not herpes zoster. Herpes zoster is common in older adults due to their weakened immune systems. Individuals undergoing radiation therapy or chemotherapy have a weakened immune system and are more likely to contract herpes zoster.

In addition, key market drivers for growth of the herpes zoster infection treatment market include rising geriatric population, coupled with rise in incidences of herpes zoster, growing awareness regarding the use of varicella vaccine, and increase in immunization programs across the world. In addition, weak immune systems make elderly people more susceptible to herpes zoster. However, dearth of skilled professionals is expected to hinder growth of the market. Conversely, increase in drug development provides lucrative growth opportunities for the market. 

Moreover, R&D investments by pharmaceutical companies and R&D activities in development of new products further boost various opportunities that lead to growth of the herpes zoster treatment market. In addition, surge in investments for research and development by leading pharmaceutical companies for development and approval of drugs for treatment of herpes zoster infection propels the market growth.

The global herpes zoster treatment market is segmented into treatment type, route of administration, distribution channel, and region. By treatment type, the market is categorized into antiviral medications, anti-inflammatory medications, and others. On the basis of route of administration, it is segregated into oral and topical. Depending on distribution channel, it is classified into hospital pharmacies, drug stores & retail pharmacies, and online providers. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA. 

On the basis of treatment type, the antiviral medication segment dominated the global herpes zoster treatment market in 2020, and is anticipated to continue this trend during the forecast period. Key factors such as rise in demand for treatment of herpes zoster and active government participation in immunization programs propel the market growth.

On the basis of route of administration, the oral segment accounts for majority of the herpes zoster treatment market share, owing to rise in oral medications such as antiviral, anti-inflammatory, and other medications, surge in demand for treatment of herpes zoster, and surge in geriatric population.

On the basis of distribution channel, the drug stores & retail pharmacies segment accounted for majority of the market share, owing to rise in diagnosis of infections, increase in awareness regarding the use of herpes zoster drugs, and increase in adoption of herpes zoster treatment.

North America accounted for majority of global herpes zoster treatment market share in 2020, and is expected to remain dominant throughout the forecast period. This is attributed to increase in geriatric population, rise in patient awareness toward treatment of herpes zoster, surge in demand drug therapies, availability of advanced healthcare facilities with trained medical professionals, presence of key players in the region, and surge in investments made by governments in the healthcare system. However, Asia-Pacific is expected to experience highest growth rate during the forecast period majorly due to improvement in healthcare infrastructure and rise in number of hospitals.

Key Findings Of The Study

• By treatment type, the antiviral medications segment held major share in the global herpes zoster treatment market in 2020.
• On the basis of route of administration, the oral segment held largest herpes zoster treatment market share in 2020, and is expected to remain dominant throughout the forecast period.
• According to distribution channel, the drug stores & retail pharmacies segment exhibits fastest growth and is expected to grow at a CAGR of 2.6% from 2021 to 2030.
• On the basis of region, Asia-Pacific is expected to experience growth at the highest rate during the forecast period.